Clinical significance of Phosphatidyl Inositol Synthase overexpression in oral cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Kaur, Jatinder ^a   Sawhney, Meenakshi ^a   DattaGupta, Siddartha ^a   Shukla, Nootan K ^b   Srivastava, Anurag ^a   Ralhan, Ranju ^a,c,d,e,f  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

^c Pediatric Oral and Maxillofacial Surgery   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYTIDINE DIPHOSPHATE DIACYLGLYCEROL INOSITOL 3 PHOSPHATIDYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; CCND1 PROTEIN, HUMAN; CDIPT PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MOUTH CANCER; ORAL SQUAMOUS CELL CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOKELESS TOBACCO; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; WESTERN BLOTTING; CELL DEDIFFERENTIATION; CONFOCAL MICROSCOPY; ENZYMOLOGY; EPITHELIUM CELL; GENETICS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PRECANCER; TUMOR CELL CULTURE; TUMOR CELL LINE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE; CELL DEDIFFERENTIATION; CELL LINE, TUMOR; CYCLIN D1; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA, ORAL; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TOBACCO, SMOKELESS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 77951596373     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-168     Document Type: Article

References (35)

1. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007, 26(3-4):645-662. 10.1007/s10555-007-9082-y, 17768600.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010, 18287387.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
4. Kademani D. Oral cancer. Mayo Clin Proc 2007, 82(7):878-887. 10.4065/82.7.878, 17605971.
5. Bettendorf O, Piffko J, Bankfalvi A. Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?. Oral Oncol 2004, 40(2):110-119. 10.1016/j.oraloncology.2003.08.010, 14693233.
6. Bankfalvi A, Piffko J. Prognostic and predictive factors in oral cancer: the role of the invasive tumour front. J Oral Pathol Med 2000, 29(7):291-298. 10.1034/j.1600-0714.2000.290701.x, 10947243.
7. Hecht SS. Progress and challenges in selected areas of tobacco carcinogenesis. Chem Res Toxicol 2008, 21(1):160-171. 10.1021/tx7002068, 2556958, 18052103.
8. Warnakulasuriya KA, Ralhan R. Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco--a review. J Oral Pathol Med 2007, 36(2):63-77.
9. Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 2004, 15(5):252-263. 10.1177/154411130401500502, 15470264.
10. Scully C, Porter S. ABC of oral health. Swellings and red, white, and pigmented lesions. Bmj 2000, 321(7255):225-228. 10.1136/bmj.321.7255.225, 1118223, 10903660.
11. Gupta PC, Mehta FS, Pindborg JJ, Bhonsle RB, Murti PR, Daftary DK, Aghi MB. Primary prevention trial of oral cancer in india: a 10-year follow-up study. J Oral Pathol Med 1992, 21(10):433-439. 10.1111/j.1600-0714.1992.tb00970.x, 1460581.
12. Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 2008, 14(4):1002-1014. 10.1158/1078-0432.CCR-07-1497, 18281532.
13. Ye H, Yu T, Temam S, Ziober BL, Wang J, Schwartz JL, Mao L, Wong DT, Zhou X. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 2008, 9:69. 10.1186/1471-2164-9-69, 2262071, 18254958.
14. Radhakrishnan R, Solomon M, Satyamoorthy K, Martin LE, Lingen MW. Tissue microarray - a high-throughput molecular analysis in head and neck cancer. J Oral Pathol Med 2008, 37(3):166-176.
15. Ralhan R, Desouza LV, Matta A, Chandra Tripathi S, Ghanny S, Datta Gupta S, Bahadur S, Siu KW. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics 2008, 7(6):1162-1173. 10.1074/mcp.M700500-MCP200, 2424195, 18339795.
16. Rohatgi N, Matta A, Kaur J, Srivastava A, Ralhan R. Novel molecular targets of smokeless tobacco (khaini) in cell culture from oral hyperplasia. Toxicology 2006, 224(1-2):1-13. 10.1016/j.tox.2006.03.014, 16730401.
17. Bussink J, Kogel AJ, Kaanders JH. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 2008, 9(3):288-296. 10.1016/S1470-2045(08)70073-1, 18308254.
18. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002, 2(7):489-501. 10.1038/nrc839, 12094235.
19. Rohatgi N, Kaur J, Srivastava A, Ralhan R. Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from an oral hyperplasia. Oral Oncol 2005, 41(8):806-820. 10.1016/j.oraloncology.2005.04.010, 15979382.
20. Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R. Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology 2006, 228(1):1-15. 10.1016/j.tox.2006.07.027, 16996673.
21. Sawhney M, Rohatgi N, Kaur J, Shishodia S, Sethi G, Gupta SD, Deo SV, Shukla NK, Aggarwal BB, Ralhan R. Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer 2007, 120(12):2545-2556. 10.1002/ijc.22657, 17354234.
22. Deguchi A, Imoto M, Umezawa K. Inhibition of G1 cyclin expression in normal rat kidney cells by inostamycin, a phosphatidylinositol synthesis inhibitor. J Biochem 1996, 120(6):1118-1122.
23. Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res 2005, 11(6):2272-2284. 10.1158/1078-0432.CCR-04-0572, 15788677.
24. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008, 37(3):127-133.
25. Imoto M, Taniguchi Y, Fujiwara H, Umezawa K. Enhancement of CDP-DG:inositol transferase activity in src- and erbB2-transformed cells. Exp Cell Res 1994, 212(1):151-154. 10.1006/excr.1994.1129, 7909754.
26. Nikawa J, Kodaki T, Yamashita S. Primary structure and disruption of the phosphatidylinositol synthase gene of Saccharomyces cerevisiae. J Biol Chem 1987, 262(10):4876-4881.
27. Deguchi A, Segawa K, Hosaka K, Weinstein IB, Umezawa K. Overexpression of phosphatidylinositol synthase enhances growth and G1 progression in NIH3T3 cells. Jpn J Cancer Res 2002, 93(2):157-166.
28. Baba Y, Tsukuda M, Mochimatsu I, Furukawa S, Kagata H, Nagashima Y, Koshika S, Imoto M, Kato Y. Cytostatic effect of inostamycin, an inhibitor of cytidine 5'-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): inositol transferase, on oral squamous cell carcinoma cell lines. Cell Biol Int 2001, 25(7):613-620. 10.1006/cbir.2000.0706, 11448100.
29. Imoto M, Taniguchi Y, Umezawa K. Inhibition of CDP-DG: inositol transferase by inostamycin. J Biochem 1992, 112(2):299-302.
30. Baba Y, Tsukuda M, Mochimatsu I, Furukawa S, Kagata H, Yoji, Nagashima, Sakai N, Koshika S, Imoto M, et al. Inostamycin, an inhibitor of cytidine 5'-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): inositol transferase, suppresses invasion ability by reducing productions of matrix metalloproteinase-2 and -9 and cell motility in HSC-4 tongue carcinoma cell line. Clin Exp Metastasis 2000, 18(3):273-279. 10.1023/A:1006798900743, 11315101.
31. West KA, Linnoila IR, Belinsky SA, Harris CC, Dennis PA. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res 2004, 64(2):446-451. 10.1158/0008-5472.CAN-03-3241, 14744754.
32. Zheng Y, Ritzenthaler JD, Roman J, Han S. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. Am J Respir Cell Mol Biol 2007, 37(6):681-690. 10.1165/rcmb.2007-0051OC, 17600315.
33. Sheng H, Shao J, Townsend CM, Evers BM. Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 2003, 52(10):1472-1478. 10.1136/gut.52.10.1472, 1773820, 12970141.
34. Fenic I, Steger K, Gruber C, Arens C, Woenckhaus J. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma. Oncol Rep 2007, 18(1):253-259.
35. Stahl U, Wenk J, Wagener F, Woenckhaus J, Gamerdinger U, Battmann A, Dreyer T. [Phosphoinositide 3-kinase (PI3-K) expression. Tumorigenesis of epithelial carcinoma of the mouth]. Pathologe 2004, 25(1):31-37. 10.1007/s00292-003-0673-2, 14767610.